Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t1-t2 and n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
This is the 2010 version of HCPCS G9109 - please refer to the 2016 HCPCS code set for the latest version.
Added on Sunday, January 01, 2006
Status changed on Monday, January 01, 2007 to: No maintenance for this code
